Praxis Precision Medicines Inc PRAX
$375.94 $11.36 (3.12%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
PRAX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Praxis Precision Medicines Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Praxis Precision Medicines Inc. Stock Analysis PRAX
United States Health Care Large Cap Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. The company is headquartered in Boston, Massachusetts and currently employs 168 full-time employees. The company went IPO on 2020-10-16. The firm is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small-molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The Company’s product candidates include ulixacaltamide, vormatrigine, relutrigine, PRAX-080, and others.
Praxis Precision Medicines Inc (PRAX) Chart
Financial Metrics & Statements of Praxis Precision Medicines Inc (PRAX)
FAQ's for Praxis Precision Medicines Inc (PRAX)
- As of August 2026, Praxis Precision Medicines Inc PRAX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Praxis Precision Medicines Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Praxis Precision Medicines Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Praxis Precision Medicines Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Praxis Precision Medicines Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Praxis Precision Medicines Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Praxis Precision Medicines Inc (PRAX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
